CHANCA PIEDRA

OTHER NAME(S):

Amli, Arranca-Pedras, Bhonya, Bhoomi Amalaki, Bhui-Amla, Bhumi Amla, Bhuianvalah, Bhuimy Amali, Bhuin Amla, Bhumy Amalaki, Bhumyamalaki, Brise Pierre, Cane Peas Senna, Cane Senna, Carry-Me-Seed, Casse-Pierre, Chancapiedra, Chanca-Piedra Blanca, Chance Pierre, Child Pick-a-Back, Creole Senna, Daun Marisan, Derriere-Dos, Des Dos, Deye Do, Dukong Anak, Elrageig, Elrigeg, Erva-Pombinha, Evatbimi, Feuilles la Fi&egrave;vre, Gale-Wind Grass, Graine En Bas Fi&egrave;vre, Graine-En-Bas-Feuille, Hurricane Weed, Jar-Amla, Jar Amla, Kizha Nelli, Malva-Pedra, Mapatan, Mekatkata, Memeniran, Meniran, Niruri, Nymphanthus niruri, Para-Parai Mi, Paraparai Mi, Pei, Phyllanto, Phyllanthus amarus, Phyllanthus carolinianus, Phyllanthus fraternus, Phyllanthus kirganella, Phyllanthus lathyroides, Phyllanthus lonphali, Phyllanthus niruri, Phyllanthus sellowianus, Pierre de Chanca, Pitirishi, Pombinha, Punarnava, Quebra Pedra, Quebrapedra, Quinina Criolla, Quinine Creole, Quinine Weed, Rami Buah, Sacha Foster, Sasha Foster, Seed on the Leaf, Semence dans la Feuille, Shka-Nin-Du, Shatter Stone, Stone Breaker, Stone-Breaker, Stonebreaker, Tamalaka, Turi Hutan, Viernes Santo, Ya-Taibai, Yaa Tai Bai, Yah-Tai-Bai, Yerba de San Pablo, Zhu Zi Cao. <br/><br/>

Overview

Overview Information

Chanca piedra is an herb. The whole plant is used to make medicine.

Chanca piedra is used for various disorders of the urinary tract including infections, pain and swelling (inflammation), kidney stones, and discharge from the urethra or vagina. It is also used for digestive tract disorders including gas, loss of appetite, stomachache, intestinal infections, constipation, and dysentery.

Some people use chanca piedra as a liver tonic and for liver problems including hepatitis B. Other uses include treating diabetes, gallstones, colic, flu, high blood pressure, sore throat and swollen tonsils, swine flu, yellowing of the skin (jaundice), abdominal tumors, pain around the rectum, fever, sexually transmitted diseases such as syphilis and gonorrhea, malaria, tumors, caterpillar stings, cough, fluid retention, itching, miscarriage, tremors, typhoid, anemia, asthma, bronchitis, thirst, tuberculosis, and dizziness.

How does it work?

It is thought that chanca piedra contains chemicals that might relieve spasms and fever, increase urine, and have activity against bacteria and viruses. It might also lower blood sugar.

Uses

Uses & Effectiveness?

Likely InEffective for

  • Hepatitis B. Taking chanca piedra by mouth for 1-6 weeks does not improve hepatitis B symptoms, decrease the duration of acute hepatitis B, or decrease markers of hepatitis B present in the blood.

Insufficient Evidence for

  • Diabetes. Early research suggests that taking chanca piedra by mouth for 7 days does not lower blood sugar in people with type 2 diabetes.
  • High blood pressure. Early research shows that taking chanca piedra by mouth for 10 days does not lower blood pressure in people with high blood pressure.
  • Kidney stones. Early research shows that taking chanca piedra by mouth for 3 months does not decrease the size or number of kidney stones in people prone to kidney stones. However, other research suggests that taking a specific product of chanca piedra (Uriston) by mouth for at least 3 months after undergoing shock wave therapy to break apart kidney stones helps the body get rid of kidney stones if they are located lower in the urinary tract.
  • Sore throat and swollen tonsils (tonsillopharyngitis). Early research suggests that taking a combination of chanca piedra and black seed by mouth for 7 days relieves pain in people with sore throat and swollen tonsils.
  • Urinary tract infections and pain and swelling (inflammation).
  • Increasing urine output.
  • Intestinal gas.
  • Increasing appetite.
  • Use as a liver tonic and blood purifier.
  • Gallstones.
  • Colic.
  • Stomachache.
  • Indigestion.
  • Intestinal infections.
  • Constipation.
  • Dysentery.
  • Flu.
  • Yellowing of the skin (jaundice).
  • Abdominal tumors.
  • Fever.
  • Pain.
  • Syphilis.
  • Gonorrhea.
  • Malaria.
  • Tumors.
  • Caterpillar stings.
  • Cough.
  • Swelling.
  • Itching.
  • Miscarriage.
  • Pain and swelling around the rectum.
  • Tremors.
  • Typhoid.
  • Infections of the vagina.
  • Anemia.
  • Asthma.
  • Bronchitis.
  • Thirst.
  • Tuberculosis.
  • Dizziness.
  • Other conditions.
More evidence is needed to rate the effectiveness of chanca piedra for these uses.

Side Effects

Side Effects & Safety

Chanca piedra is POSSIBLY SAFE when taken by mouth for a short time period (up to 3 months).

It is not known if chanca piedra causes side effects.

Special Precautions & Warnings:

Pregnancy and breast-feeding: Chanca piedra is POSSIBLY UNSAFE when taken by mouth by pregnant women or those trying to become pregnant. Chanca piedra in large amounts may block pregnancy, increase the risk of low birth weight, or increase the risk of birth defects.

There is not enough reliable information about the safety of taking chanca piedra if you are breast-feeding. Stay on the safe side and avoid use.

Bleeding disorder: Chanca piedra might slow blood clotting. There is a concern that taking chanca piedra might cause bleeding in people with bleeding disorders.

Diabetes: Chanca piedra might affect blood sugar levels. Watch for signs of low blood sugar (hypoglycemia) and monitor your blood sugar carefully if you have diabetes and use chanca piedra.

Surgery: Chanca piedra might lower blood sugar levels. There is some concern that it might interfere with blood sugar control during and after surgery. Chanca piedra might also slow blood clotting and increase the risk of bleeding. Stop using chanca piedra at least 2 weeks before a scheduled surgery.

Interactions

Interactions?

Moderate Interaction

Be cautious with this combination

!
  • Lithium interacts with CHANCA PIEDRA

    Chanca piedra might have an effect like a water pill or "diuretic." Taking chanca piedra might decrease how well the body gets rid of lithium. This could increase how much lithium is in the body and result in serious side effects. Talk with your healthcare provider before using this product if you are taking lithium. Your lithium dose might need to be changed.

  • Medications for diabetes (Antidiabetes drugs) interacts with CHANCA PIEDRA

    Chanca piedra might decrease blood sugar. Diabetes medications are also used to lower blood sugar. Taking chanca piedra along with diabetes medications might cause your blood sugar to go too low. Monitor your blood sugar closely. The dose of your diabetes medication might need to be changed.<br><nb>Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase), and others.

Dosing

Dosing

The appropriate dose of chanca piedra depends on several factors such as the user's age, health, and several other conditions. At this time there is not enough scientific information to determine an appropriate range of doses for chanca piedra. Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.

View References

REFERENCES:

  • Patel S, Sharma V, S Chauhan N, Thakur M, Dixit VK. Evaluation of hair growth promoting activity of Phyllanthus niruri. Avicenna J Phytomed. 2015;5(6):512-9. View abstract.
  • Qian-Cutrone J, Huang S, Trimble J, et al. Niruriside, a new HIV REV/RRE binding inhibitor from Phyllanthus niruri. J Nat Prod 1996;59:196-9. View abstract.
  • Raintree tropical plant database, Amazon plants. www.rain-tree.com/plants.htm (Accessed 30 July 1999).
  • Srividya N, Periwal S. Diuretic, hypotensive and hypoglycaemic effect of Phyllanthus amarus. Indian J Exp Biol 1995; 33:861-4. View abstract.
  • Wang M, Cheng H, Li Y, et al. Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observations with three preparations from different geographic sites. J Lab Clin Med 1995;126:350-2. View abstract.
  • Wei W, Li X, Wang K, Zheng Z, Zhou M. Lignans with anti-hepatitis B virus activities from Phyllanthus niruri L. Phytother Res. 2012;26(7):964-8. View abstract.
  • Abdulla MA, Ahmed KA Al-Bayaty FH et al. Gastroprotective effect of Phyllanthus niruri leaf extract against ethanol-induced gastric mucosal injury in rats. African Journal of Pharmacy and Pharmacology 2010;226-230.
  • Abhyankar G, Suprasanna P Pandey BN et al. Hairy root extract of Phyllanthus amarus induces apoptotic cell death in human breast cancer cells. Innovative Food Science & Emerging Technologies 2010;526-532.
  • Adedapo, A. A., Abatan, M. O., Akinloye, A. K., Idowu, S. O., and Olorunsogo, O. O. Morphometric and histopathological studies on the effects of some chromatographic fractions of Phyllanthus amarus and Euphorbia hirta on the male reproductive organs of rats. J Vet.Sci 2003;4(2):181-185. View abstract.
  • Adedapo, A. A., Adegbayibi, A. Y., and Emikpe, B. O. Some clinico-pathological changes associated with the aqueous extract of the leaves of Phyllanthus amarus in rats. Phytother.Res 2005;19(11):971-976. View abstract.
  • Adeneye AA, Benebo AS Agbaje EO. Protective effect of the aqueous leaf and seed extract of Phyllanthus amarus on alcohol-induced hepatotoxicity in rats. West African Journal of Pharmacology and Drug Research 2007;42-50.
  • Adeneye, A. A. and Benebo, A. S. Protective effect of the aqueous leaf and seed extract of Phyllanthus amarus on gentamicin and acetaminophen-induced nephrotoxic rats. J Ethnopharmacol. 7-23-2008;118(2):318-323. View abstract.
  • Adeneye, A. A., Amole, O. O., and Adeneye, A. K. Hypoglycemic and hypocholesterolemic activities of the aqueous leaf and seed extract of Phyllanthus amarus in mice. Fitoterapia 2006;77(7-8):511-514. View abstract.
  • Adjene, JO. Histological effects of chronic administration of Phyllanthus amarus on the superior colliculus of adult wistar rats. African Journal of Biotechnology 2010;3919-3922.
  • Ahmeda, A., Hossain, M. A., and Zhari Ismail. Antioxidant properties of the isolated flavonoids from the medicinal plant Phyllanthus niruri. Asian Journal of Food and Agro-Industry 2009;2(3)
  • Ajala, T. O., Igwilo, C. I., Oreagba, I. A., and Odeku, O. A. The antiplasmodial effect of the extracts and formulated capsules of Phyllanthus amarus on Plasmodium yoelii infection in mice. Asian Pac.J Trop.Med 2011;4(4):283-287. View abstract.
  • Ali, H., Houghton, P. J., and Soumyanath, A. alpha-Amylase inhibitory activity of some Malaysian plants used to treat diabetes; with particular reference to Phyllanthus amarus. J Ethnopharmacol. 10-11-2006;107(3):449-455. View abstract.
  • Amaechina, F. C. and Omogbai, E. K. Hypotensive effect of aqueous extract of the leaves of Phyllanthus amarus Schum and Thonn (Euphorbiaceae). Acta Pol.Pharm. 2007;64(6):547-552. View abstract.
  • Andrew EO, Enogieru A. Effects of oral administration of Phyllanthus amarus leaf extract on the kidneys of adult Wistar rats - a histological study. African Journal of Traditional, Complementary and Alternative Medicines 2011;307-311.
  • Bagchi GD, Choudhuri PK Kumar S. Registration of a cultivar of the medicinal plant bhumyamalaki Phyllanthus amarus. Journal of Medicinal and Aromatic Plant Sciences 1999;21(1):51.
  • Barros, M. E., Lima, R., Mercuri, L. P., Matos, J. R., Schor, N., and Boim, M. A. Effect of extract of Phyllanthus niruri on crystal deposition in experimental urolithiasis. Urol.Res 2006;34(6):351-357. View abstract.
  • Berk, L., de Man, R. A., Schalm, S. W., Labadie, R. P., and Heijtink, R. A. Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed. J Hepatol. 1991;12(3):405-406. View abstract.
  • Bharathi KN, Dattani V. Evaluation of type-I anti-diabetic activity of Phyllanthus niruri and combination of Phyllanthus niruri and Gymnema sylvestre. Asian Journal of Experimental Sciences 2010;
  • Bhattacharyya R, Bhattacharya S Wenzel-Mathers M et al. Phyllanthus amarus root clone with significant activity against bovine viral diarrhoea virus - a surrogate model of hepatitis C virus. Current Science 2003;84(4):529-533.
  • Blumberg, B. S., Millman, I., Venkateswaran, P. S., and Thyagarajan, S. P. Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus. Cancer Detect.Prev. 1989;14(2):195-201. View abstract.
  • Blumberg, B. S., Millman, I., Venkateswaran, P. S., and Thyagarajan, S. P. Hepatitis B virus and primary hepatocellular carcinoma: treatment of HBV carriers with Phyllanthus amarus. Vaccine 1990;8 Suppl:S86-S92. View abstract.
  • Boim, M. A., Heilberg, I. P., and Schor, N. Phyllanthus niruri as a promising alternative treatment for nephrolithiasis. Int.Braz.J Urol. 2010;36(6):657-664. View abstract.
  • Brook, M. G. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 10-29-1988;2(8618):1017-1018. View abstract.
  • Campos, A. H. and Schor, N. Phyllanthus niruri inhibits calcium oxalate endocytosis by renal tubular cells: its role in urolithiasis. Nephron 1999;81(4):393-397. View abstract.
  • Chezhiyan N, Saraswathy S Vasumathi R. Studies on organic manures, biofertilizers and plant density on growth, yield and alkaloid content of bhumyamalaki (Phyllanthus amarus Schum. and Thonn.). South Indian Horticulture 2003;51:96-101.
  • Chitra R, Vadivel E Rajamani K. Estimation of anti-hepatic viral compounds in Phyllanthus amarus in vitro cultures. Journal of Horticultural Sciences 2008;62-65.
  • Cimanga, R. K., Tona, L., Luyindula, N., Mesia, K., Lusakibanza, M., Musuamba, C. T., Apers, S., De, Bruyne T., Van, Miert S., Hermans, N., Totte, J., Pieters, L., and Vlietinck, A. J. In vitro antiplasmodial activity of callus culture extracts and fractions from fresh apical stems of Phyllanthus niruri L. (Euphorbiaceae): part 2. J Ethnopharmacol. 2004;95(2-3):399-404. View abstract.
  • Dirjomuljono, M., Kristyono, I., Tjandrawinata, R. R., and Nofiarny, D. Symptomatic treatment of acute tonsillo-pharyngitis patients with a combination of Nigella sativa and Phyllanthus niruri extract. Int J Clin Pharmacol.Ther 2008;46(6):295-306. View abstract.
  • Doshi, J. C., Vaidya, A. B., Antarkar, D. S., Deolalikar, R., and Antani, D. H. A two-stage clinical trial of Phyllanthus amarus in hepatitis B carriers: failure to eradicate the surface antigen. Indian J Gastroenterol. 1994;13(1):7-8. View abstract.
  • Etta H. Effects of Phyllanthus amarus on litter traits in albino rats. Scientific Research and Essays 2008;370-372.
  • Etta HE, Udoh PB Asuquo BO et al. Effect of Phyllanthus amarus on breeding efficiency of female albino rats. Global Journal of Agricultural Sciences 2007;215-217.
  • Faremi, T. Y., Suru, S. M., Fafunso, M. A., and Obioha, U. E. Hepatoprotective potentials of Phyllanthusamarus against ethanol-induced oxidative stress in rats. Food Chem Toxicol. 2008;46(8):2658-2664. View abstract.
  • Foo LY. Amariin, a di-dehydrohexahydroxydiphenoyl hydrolysable tannin from Phyllanthus amarus. Phytochemistry 1993;33(2):487-491.
  • Foo LY. Amariinic acid and related ellagitannins from Phyllanthus amarus. Phytochemistry 1995;39(1):217-224.
  • Freitas, A. M., Schor, N., and Boim, M. A. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation. BJU.Int. 2002;89(9):829-834. View abstract.
  • Gupta AK, Khanuja SP Gupta MM et. al. High herb, phyllanthin and hypophyllanthin yielding variety of bhumyamalaki (Phyllanthus amarus): Cim-Jeevan. Journal of Medicinal and Aromatic Plant Sciences 2003;25(3):743-745.
  • Harikumar, K. B., Kuttan, G., and Kuttan, R. Inhibition of viral carcinogenesis by Phyllanthus amarus. Integr.Cancer Ther. 2009;8(3):254-260. View abstract.
  • Harikumar, K. B., Kuttan, G., and Kuttan, R. Phyllanthus amarus inhibits cell growth and induces apoptosis in Dalton's lymphoma ascites cells through activation of caspase-3 and downregulation of Bcl-2. Integr.Cancer Ther. 2009;8(2):190-194. View abstract.
  • Huang ZR, Zhong JP, and Zhu GL. Therapeutic observation of Phyllanthus amarus for treatment of hepatitis B . The Cochrane Library 1993;(1)
  • Hussain RA, Dickey JK Rosser MP et al. A novel class on non-peptidic endothelin antagonists isolated from the medicinal herb Phyllanthus niruri. Journal of Natural Products 1995;1515-1520.
  • Iizuka, T., Moriyama, H., and Nagai, M. Vasorelaxant effects of methyl brevifolincarboxylate from the leaves of Phyllanthus niruri. Biol.Pharm.Bull. 2006;29(1):177-179. View abstract.
  • Iizuka, T., Nagai, M., Taniguchi, A., Moriyama, H., and Hoshi, K. Inhibitory effects of methyl brevifolincarboxylate isolated from Phyllanthus niruri L. on platelet aggregation. Biol.Pharm.Bull. 2007;30(2):382-384. View abstract.
  • Jayaram S, Thyagarajan SP Sumathi S et al. Efficacy of Phyllanthus amarus treatment in acute viral hepatitis A, B and non A non B: an open clinical trial. Indian Journal of Virology 1997;13(1):59-64.
  • Jayaram, S. and Thyagarajan, S. P. Inhibition of HBsAg secretion from Alexander cell line by Phyllanthus amarus. Indian J Pathol.Microbiol. 1996;39(3):211-215. View abstract.
  • Jeena, K. J., Joy, K. L., and Kuttan, R. Effect of Emblica officinalis, Phyllanthus amarus and Picrorrhiza kurroa on N-nitrosodiethylamine induced hepatocarcinogenesis. Cancer Lett. 2-8-1999;136(1):11-16. View abstract.
  • Joshi H, Parle M. Evaluation of the antiamnesic effects of Phyllanthus amarus in mice. Colombia Medica 2007;132-139.
  • Joy KL, Kuttan R. Inhibition by Phyllanthus amarus of hepatocarcinogenesis induced by N-nitrosodiethylamine. Journal of Clinical Biochemistry and Nutrition 1998;24(3):133-139.
  • Karuna, R., Reddy, S. S., Baskar, R., and Saralakumari, D. Antioxidant potential of aqueous extract of Phyllanthus amarus in rats. Indian J Pharmacol. 2009;41(2):64-67. View abstract.
  • Khanna, A. K., Rizvi, F., and Chander, R. Lipid lowering activity of Phyllanthus niruri in hyperlipemic rats. J Ethnopharmacol. 2002;82(1):19-22. View abstract.
  • Kiemer, A. K., Hartung, T., Huber, C., and Vollmar, A. M. Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-kappaB pathway. J Hepatol. 2003;38(3):289-297. View abstract.
  • Kumar MS, Jaiprakash B Hukkeri VI. Preventive effect of Phyllanthus amarus on prostatic hyperplasia. Hamdard Medicus 2006;114-117.
  • Kumar NG, Nair AN Raghunandanan VR et al. Hypoglycaemic effect of Phyllanthus niruri leaves in rabbits. Kerala Journal of Veterinary Science 1989;20(1):77-80.
  • Kumar, K. B. and Kuttan, R. Chemoprotective activity of an extract of Phyllanthus amarus against cyclophosphamide induced toxicity in mice. Phytomedicine. 2005;12(6-7):494-500. View abstract.
  • Lee, C. D., Ott, M., Thyagarajan, S. P., Shafritz, D. A., Burk, R. D., and Gupta, S. Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication. Eur J Clin Invest 1996;26(12):1069-1076. View abstract.
  • Leelarasamee, A., Trakulsomboon, S., Maunwongyathi, P., Somanabandhu, A., Pidetcha, P., Matrakool, B., Lebnak, T., Ridthimat, W., and Chandanayingyong, D. Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen from symptomless carriers. Lancet 6-30-1990;335(8705):1600-1601. View abstract.
  • Londhe, J. S., Devasagayam, T. P., Foo, L. Y., and Ghaskadbi, S. S. Antioxidant activity of some polyphenol constituents of the medicinal plant Phyllanthus amarus Linn. Redox.Rep. 2008;13(5):199-207. View abstract.
  • Londhe, J. S., Devasagayam, T. P., Foo, L. Y., and Ghaskadbi, S. S. Radioprotective properties of polyphenols from Phyllanthus amarus Linn. J Radiat.Res 2009;50(4):303-309. View abstract.
  • Luyindula, N, Tona, L, Lunkebila, S, Cimanga, RK, Vlietinck, AJ, and et al. In vitro antiplasmodial activity of callus culture extracts from fresh apical stems of Phyllanthus niruri: Part 1. Pharmaceutical Biology (Netherlands) 2004;42:512-518.
  • Mahat MA, Patil BM. Evaluation of antiinflammatory activity of methanol extract of Phyllanthus amarus in experimental animal models. Indian Journal of Pharmaceutical Sciences 2007;33-36.
  • McPartland JM. Viral hepatitis treated with Phyllanthus amarus and milk thistle (Silybum marianum): a case report [corrected]. Complementary Medicine International 1996;3(2):40-42.
  • Micali, S., Sighinolfi, M. C., Celia, A., De, Stefani S., Grande, M., Cicero, A. F., and Bianchi, G. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study. J Urol. 2006;176(3):1020-1022. View abstract.
  • Milne, A., Hopkirk, N., Lucas, C. R., Waldon, J., and Foo, Y. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. N.Z.Med J 6-22-1994;107(980):243. View abstract.
  • Moshi MJ, Uiso FC Mahunnah RL et al. A study of the effect of Phyllanthus amarus extracts on blood glucose in rabbits. International Journal of Pharmacognosy 1997;35(3):167-173.
  • Moshi, M. J., Lutale, J. J., Rimoy, G. H., Abbas, Z. G., Josiah, R. M., and Swai, A. B. The effect of Phyllanthus amarus aqueous extract on blood glucose in non-insulin dependent diabetic patients. Phytother.Res 2001;15(7):577-580. View abstract.
  • Munshi, A., Mehrotra, R., and Panda, S. K. Evaluation of Phyllanthus amarus and Phyllanthus maderaspatensis as agents for postexposure prophylaxis in neonatal duck hepatitis B virus infection. J Med Virol. 1993;40(1):53-58. View abstract.
  • Munshi, A., Mehrotra, R., Ramesh, R., and Panda, S. K. Evaluation of anti-hepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis B virus carrier Pekin ducks. J Med Virol. 1993;41(4):275-281. View abstract.
  • Murugaiyah, V. and Chan, K. L. Antihyperuricemic lignans from the leaves of Phyllanthus niruri. Planta Med 2006;72(14):1262-1267. View abstract.
  • Murugaiyah, V. and Chan, K. L. Determination of four lignans in Phyllanthus niruri L. by a simple high-performance liquid chromatography method with fluorescence detection. J Chromatogr.A 6-22-2007;1154(1-2):198-204. View abstract.
  • Mustofa, Sholikhah, E. N., and Wahyuono, S. In vitro and in vivo antiplasmodial activity and cytotoxicity of extracts of Phyllanthus niruri L. herbs traditionally used to treat malaria in Indonesia. Southeast Asian J Trop.Med Public Health 2007;38(4):609-615. View abstract.
  • Musuamba CT, Cimanga RK Dooghe L et al. In vitro antiplasmodial and cytotoxic activities of ethanol extracts of apical stem of Phyllanthus amarus Schum. et Thonn. (Euphorbiaceae). Journal of Complementary and Integrative Medicine 2010;7(1)
  • Myint MM, Than MA Lwin KK et al. Preliminary study on hypoglycemic effect of Phyllanthus niruri Linn. (Taung-ze-phyu) on rabbit model. Myanmar Health Sciences Research Journal 2009;17-21.
  • Naik, A. D. and Juvekar, A. R. Effects of alkaloidal extract of Phyllanthus niruri on HIV replication. Indian J Med Sci 2003;57(9):387-393. View abstract.
  • Narendranathan M, Mini PC Remla A. A trial of Phyllanthus amarus in acute viral hepatitis [abstract]. J-Clin-Epidemiol 1997;50(8S)
  • Narendranathan, M., Remla, A., Mini, P. C., and Satheesh, P. A trial of Phyllanthus amarus in acute viral hepatitis. Trop.Gastroenterol. 1999;20(4):164-166. View abstract.
  • Navarro M, Coussio J Hnatyszyn O et al. Hypoglycemic Effect of an Aqueous Extract of Phyllanthus sellowianus ("sarandi blanco") in C57BL/Ks mice. Acta Farmaceutica Bonaerense 2004;23:520-523.
  • Nishiura, J. L., Campos, A. H., Boim, M. A., Heilberg, I. P., and Schor, N. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients. Urol.Res 2004;32(5):362-366. View abstract.
  • Nitnaware KM, Naik DG Nikam TD. Thidiazuron-induced shoot organogenesis and production of hepatoprotective lignan phyllanthin and hypophyllanthin in Phyllanthus amarus. Plant Cell, Tissue and Organ Culture 2011;101-110.
  • Niu, J. Z., Wang, Y. Y., Qiao, M., Gowans, E., Edwards, P., Thyagarajan, S. P., Gust, I., and Locarnini, S. Effect of Phyllanthus amarus on duck hepatitis B virus replication in vivo. J Med Virol. 1990;32(4):212-218. View abstract.
  • Notka, F., Meier, G. R., and Wagner, R. Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus. Antiviral Res 2003;58(2):175-186. View abstract.
  • Notka, F., Meier, G., and Wagner, R. Concerted inhibitory activities of Phyllanthus amarus on HIV replication in vitro and ex vivo. Antiviral Res 2004;64(2):93-102. View abstract.
  • Odetola, A. A. and Akojenu, S. M. Anti-diarrhoeal and gastro-intestinal potentials of the aqueous extract of Phyllanthus amarus (Euphorbiaceae). Afr.J Med Med Sci 2000;29(2):119-122. View abstract.
  • Ogata, T., Higuchi, H., Mochida, S., Matsumoto, H., Kato, A., Endo, T., Kaji, A., and Kaji, H. HIV-1 reverse transcriptase inhibitor from Phyllanthus niruri. AIDS Res Hum.Retroviruses 1992;8(11):1937-1944. View abstract.
  • Okoli CO, Ibiam AF Ezike AC et al. Evaluation of antidiabetic potentials of Phyllanthus niruri in alloxan diabetic rats. African Journal of Biotechnology 2010;248-259.
  • Okoli, C. O., Obidike, I. C., Ezike, A. C., Akah, P. A., and Salawu, O. A. Studies on the possible mechanisms of antidiabetic activity of extract of aerial parts of Phyllanthus niruri. Pharm.Biol. 2011;49(3):248-255. View abstract.
  • Pagare RS, Auti SG Aglave BA et al. Protocol for callus culture of Phyllanthus amarus Schum and Thonn. and possibility of use of callus culture in production of phyllanthin and hypophyllanthin. Advances in Plant Sciences 2009;433-436.
  • Patel HJ, Patel JS Patel KN. Clinical study of hepatoprotective drug Phyllanthus amarus. Research Journal of Pharmaceutical Biological and Chemical Sciences. Research Journal of Pharmaceutical Biological and Chemical Sciences 2010;335-340.
  • Pramyothin, P., Ngamtin, C., Poungshompoo, S., and Chaichantipyuth, C. Hepatoprotective activity of Phyllanthus amarus Schum. et. Thonn. extract in ethanol treated rats: in vitro and in vivo studies. J Ethnopharmacol. 11-1-2007;114(2):169-173. View abstract.
  • Rajeshkumar, N. V. and Kuttan, R. Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol. 2000;73(1-2):215-219. View abstract.
  • Rajeshkumar, N. V., Joy, K. L., Kuttan, G., Ramsewak, R. S., Nair, M. G., and Kuttan, R. Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J Ethnopharmacol. 2002;81(1):17-22. View abstract.
  • Rao, M. V. and Alice, K. M. Contraceptive effects of Phyllanthus amarus in female mice. Phytother.Res 2001;15(3):265-267. View abstract.
  • Raphael, K. R. and Kuttan, R. Inhibition of experimental gastric lesion and inflammation by Phyllanthus amarus extract. J Ethnopharmacol. 2003;87(2-3):193-197. View abstract.
  • Raphael, K. R., Sabu, M. C., and Kuttan, R. Hypoglycemic effect of methanol extract of Phyllanthus amarus Schum & Thonn on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential. Indian J Exp.Biol. 2002;40(8):905-909. View abstract.
  • Raphael, K. R., Sabu, M., Kumar, K. H., and Kuttan, R. Inhibition of N-Methyl N'-nitro-N-nitrosoguanidine (MNNG) induced gastric carcinogenesis by Phyllanthus amarus extract. Asian Pac.J Cancer Prev. 2006;7(2):299-302. View abstract.
  • Ravikumar, Y. S., Ray, U., Nandhitha, M., Perween, A., Raja, Naika H., Khanna, N., and Das, S. Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Res 2011;158(1-2):89-97. View abstract.
  • Sarkar MK, Kinter M Mazumder B et al. Purification and characterisation of a novel antioxidant protein molecule from Phyllanthus niruri. Food Chemistry 2009;1405-1412.
  • Sharma, P., Parmar, J., Verma, P., and Goyal, P. K. Modulatory influence of Phyllanthus niruri on oxidative stress, antioxidant defense and chemically induced skin tumors. J Environ.Pathol.Toxicol.Oncol. 2011;30(1):43-53. View abstract.
  • Sharma, P., Parmar, J., Verma, P., Sharma, P., and Goyal, P. K. Anti-tumor activity of Phyllanthus niruri (a medicinal plant) on chemical-induced skin carcinogenesis in mice. Asian Pac.J Cancer Prev. 2009;10(6):1089-1094. View abstract.
  • Singh B, Agrawal PK Thakur RS. A new lignan and a new neolignan from Phyllanthus niruri. Journal of Natural Products 1989;48-51.
  • Subeki, S., Matsuura, H., Takahashi, K., Yamasaki, M., Yamato, O., Maede, Y., Katakura, K., Kobayashi, S., Trimurningsih, T., Chairul, C., and Yoshihara, T. Anti-babesial and anti-plasmodial compounds from Phyllanthus niruri. J Nat.Prod. 2005;68(4):537-539. View abstract.
  • Syamasundar, K. V., Singh, B., Thakur, R. S., Husain, A., Kiso, Y., and Hikino, H. Antihepatotoxic principles of Phyllanthus niruri herbs. J Ethnopharmacol. 1985;14(1):41-44. View abstract.
  • Tamil, I. G., Dineshkumar, B., Nandhakumar, M., Senthilkumar, M., and Mitra, A. In vitro study on alpha-amylase inhibitory activity of an Indian medicinal plant, Phyllanthus amarus. Indian J Pharmacol. 2010;42(5):280-282. View abstract.
  • Thamlikitkul, V., Wasuwat, S., and Kanchanapee, P. Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers. J Med Assoc.Thai. 1991;74(9):381-385. View abstract.
  • Thyagarajan, S. P., Jayaram, S., Valliammai, T., Madanagopalan, N., Pal, V. G., and Jayaraman, K. Phyllanthus amarus and hepatitis B. Lancet 10-13-1990;336(8720):949-950. View abstract.
  • Thyagarajan, S. P., Subramanian, S., Thirunalasundari, T., Venkateswaran, P. S., and Blumberg, B. S. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 10-1-1988;2(8614):764-766. View abstract.
  • Thyagarajan, S. P., Thiruneelakantan, K., Subramanian, S., and Sundaravelu, T. In vitro inactivation of HBsAg by Eclipta alba Hassk and Phyllanthus niruri Linn. Indian J Med Res 1982;76 Suppl:124-130. View abstract.
  • Tona, L., Mesia, K., Ngimbi, N. P., Chrimwami, B., Okond'ahoka, Cimanga, K., De, Bruyne T., Apers, S., Hermans, N., Totte, J., Pieters, L., and Vlietinck, A. J. In-vivo antimalarial activity of Cassia occidentalis, Morinda morindoides and Phyllanthus niruri. Ann.Trop.Med Parasitol. 2001;95(1):47-57. View abstract.
  • Udupa AL, Sanjeeva Benegal A. Diuretic activity of Phyllanthus niruri (Linn.) in rats. Health 2010;511-512.
  • Venkateswaran, P. S., Millman, I., and Blumberg, B. S. Effects of an extract from Phyllanthus niruri on hepatitis B and woodchuck hepatitis viruses: in vitro and in vivo studies. Proc.Natl.Acad.Sci U.S.A 1987;84(1):274-278. View abstract.
  • Wang LT, He Y Ren JW Jiang J et al. Clinic study on chronic HBV infection treated by Phyllanthus amarus. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1992;6-9.
  • Wang XH, Li CQ Guo XB et al. Clinical observation on 40 cases of chronic hepatitis B using compound Phyllanthus amarus combined with interferon. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1999;12-31.
  • Woottisin, S., Hossain, R. Z., Yachantha, C., Sriboonlue, P., Ogawa, Y., and Saito, S. Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on risk factors for urinary calcium oxalate stones in rats. J Urol. 2011;185(1):323-328. View abstract.
  • Xin-Hua, W., Chang-Qing, L., Xing-Bo, G., and Lin-Chun, F. A comparative study of Phyllanthus amarus compound and interferon in the treatment of chronic viral hepatitis B. Southeast Asian J Trop.Med Public Health 2001;32(1):140-142. View abstract.
  • Yeh, S. F., Hong, C. Y., Huang, Y. L., Liu, T. Y., Choo, K. B., and Chou, C. K. Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells. Antiviral Res 1993;20(3):185-192. View abstract.
  • Zhang JL, He WN Ye P. Clinic observation on Phyllanthus amarus for treating chronic HBV infection. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1992;8-10.
  • Zhu FM, Zhang JQ Zhang XZ et al. Observation on the effect of fujian's Phyllanthus amarus in treatment of HBV infection. Chinese Journal of Integrated Traditional & Western Medicine on Liver Diseases 1992;10-11.
  • Agri Res Svc: Dr. Duke's phytochemical and ethnobotanical databases. www.ars-grin.gov/duke (Accessed 3 November 1999).
  • Araújo RF Jr, Soares LA, da Costa Porto CR, et al. Growth inhibitory effects of Phyllanthus niruri extracts in combination with cisplatin on cancer cell lines. World J Gastroenterol. 2012;18(31):4162-6168. View abstract.
  • Asare GA, Addo P, Bugyei K, et al. Acute toxicity studies of aqueous leaf extract of Phyllanthus niruri. Interdiscip Toxicol. 2011;4(4):206-10. View abstract.
  • Asare GA, Bugyei K, Sittie A, et al. Genotoxicity, cytotoxicity and toxicological evaluation of whole plant extracts of the medicinal plantPhyllanthus niruri (Phyllanthaceae). Genet Mol Res. 2012;11(1):100-11. View abstract.
  • Boim MA, Heilberg IP, Schor N. Phyllanthus niruri as a promising alternative treatment for nephrolithiasis. Int Braz J Urol. 2010;36(6):657-64; discussion 664. Review. View abstract.
  • Bruneton J. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavoisier Publishing, 1995.
  • Calixto JB. Antispasmodic effects of an alkaloid extracted from Phyllanthus sellowianus: A comparative study with papaverine. Braz J Med Biol Res 1984; 17:313-21. View abstract.
  • Celia A, Micali S Sighinolfi M et al. May phyllanthus niruri (Uriston&reg;) affect the efficacy of ESWL on renal stones? A prospective, randomised short term study [abstract no: 178] . The Cochrane Library 2005;(1)
  • Colpo E, Vilanova CD, Pereira RP, et al. Antioxidant effects of Phyllanthus niruri tea on healthy subjects. Asian Pac J Trop Med. 2014;7(2):113-8. View abstract.
  • de Araújo Júnior RF, de Souza TP, Pires JG, et al. A dry extract of Phyllanthus niruri protects normal cells and induces apoptosis in human liver carcinoma cells. Exp Biol Med (Maywood). 2012;237(11):1281-8. View abstract.
  • Duke JA, Vasquez R. Amazonian Ethnobotanical Dictionary. Boca Raton, FL: CRC Press, LLC 1994.
  • Germplasm Resources Info. www.ars-grin.gov/npgs (Accessed 3 November 1999).
  • Ibrahim D, Hong LS, Kuppan N. Antimicrobial activity of crude methanolic extract from Phyllanthus niruri. Nat Prod Commun. 2013;8(4):493-6. View abstract.
  • Koay YH, Basiri A, Murugaiyah V, et al. Isocorilagin, a cholinesterase inhibitor from Phyllanthus niruri. Nat Prod Commun. 2014;9(4):515-7. View abstract.
  • Lee NY, Khoo WK, Adnan MA, et al. The pharmacological potential of Phyllanthus niruri. J Pharm Pharmacol. 2016;68(8):953-69. View abstract.
  • Milne A, Hopkirk N, Lucas CR, et al. Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus. N Z Med J 1994;107:243.
  • Moreira J, Klein-Júnior LC, Cechinel Filho V, de Campos Buzzi F. Anti-hyperalgesic activity of corilagin, a tannin isolated from Phyllanthus niruri L. (Euphorbiaceae). J Ethnopharmacol. 2013;146(1):318-23. View abstract.

More Resources for CHANCA PIEDRA

CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.

This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
© Therapeutic Research Faculty 2018.